Sun.Feb 16, 2025

article thumbnail

PD1 x VEGF bispecific landscape: examining Hope versus Hype.

SugarCone Biotech

There were waves of interest in this therapeutic space at ASCO in June 2024 and around the JP Morgan healthcare conference in January 2025. Here we take a look at the hope and the hype behind the PD1/VEGF bispecific therapeutics.

82
article thumbnail

Flu and Stomach Bugs Are Spreading Fast—Are You Prepared?

Drugs.com

SUNDAY, Feb. 16, 2025 -- Flu season is in full swing, making it more important than ever to take steps to protect yourself and your loved ones.Dr. Priya Soni, a pediatric infectious disease specialist at Cedars-Sinai Guerin Childrens Health Center.

Disease 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Making of a Gene Circuit

Codon

This article is best experienced on our website. In the late 1990s, a young physicist named Michael Elowitz decided to “program” living cells. A graduate student at Princeton University, Elowitz was spending a great deal of his free time poring over esoteric papers about circadian clocks, the molecular networks that control an organism’s behavior in roughly 24-hour cycles. “And as I’m reading all of these papers,” he told Asimov Press , “I noticed that m

DNA 52
article thumbnail

Strategies for successful biosimilar-to-biosimilar switching

Drug Patent Watch

The Future of Biosimilars: Switching Strategies for Success As the biosimilar market continues to grow, pharmaceutical companies are looking for innovative ways to stay ahead of the competition. One strategy that's gaining traction is biosimilar-to-biosimilar switching. But what does this mean, and how can you make it work for your business? Biosimilar-to-biosimilar switching involves switching patients from one biosimilar to another, often to improve efficacy, reduce costs, or enhance patient o

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven